Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 77-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Oral and Oral Sustained-Release Rilmenidine in Healthy Volunteers and Correlation with In Vitro Sustained-Release Properties

By de Visser S.J.   Vis P.W.   van Gerven J.M.A.   Schoemaker R.C.   Cohen A.F.  

Clinical Drug Investigation, Vol. 21, Iss. 8, 2001-08 ,pp. : 579-586

Adis International

Access to resources Recommend Favorite

Bioequivalence Study of Two Ibuprofen Formulations Administered Intravenously in Healthy Male Volunteers

By D. Chassard  

Clinical Drug Investigation, Vol. 24, Iss. 12, 2004-01 ,pp. : 739-747

Adis International

Access to resources Recommend Favorite

Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioequivalence of Rebamipide Granules and Tablets in Healthy Adult Male Volunteers

By Hasegawa S.  

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 771-779

Adis International

Access to resources Recommend Favorite